Protein phosphatase 2A (PP2A) plays central roles in development, cell growth and transformation. Inactivation of the gene encoding the PP2A catalytic subunit Ca by gene targeting generates a lethal embryonic phenotype. No mesoderm is formed in Ca 2/2 embryos. Here, we found that during normal early embryonic development Ca was predominantly present at the plasma membrane whereas the highly homologous isoform Cb was localized to the cytoplasm and nuclei, suggesting the inability of Cb to compensate for vital functions of Ca in Ca 2/2 embryos. In addition, PP2A was found in a complex containing the PP2A substrates E-cadherin and b-catenin. In Ca
Introduction
Protein phosphatase 2A (PP2A) is a serine/threoninedirected protein phosphatase with important roles in development, cell growth and transformation. It accounts for a signi®cant portion of the total phosphatase activity in many tissues and cell types (Shenolikar, 1994) . All PP2A holoenzymes have in common a 36 kDa catalytic subunit (C) and a 65 kDa structural subunit (A). These core subunits assemble with regulatory subunits (B) of various sizes to form functionally distinct heterotrimers . In Drosophila, the catalytic subunit appears to be encoded by a single gene, whereas two homologous isoforms with 97% amino acid identity, Ca and Cb , exist in mammals (Orgad et al., 1990; Go Ètz and Kues, 1999) . Possible functional differences of the two isoforms are unknown. We have recently shown by a gene targeting approach in mouse that the two subunits most likely have distinct functions (Go Ètz et al., 1998) : Ca 2/2 mice have a lethal embryonic phenotype with premature death at embryonic day 6.5, when under normal circumstances gastrulation is initiated and mesoderm is formed. Analysis of these mice showed that Ca is not essential before embryonic day 6.5. By using both speci®c antisera for Ca and Cb as well as an anti-Ca/ b antiserum we found that levels of Cb are much higher than those of Ca. Thus, Cb may fail to dephosphorylate substrates of Ca (Go Ètz et al., 1998) , and this substrate speci®city may be related to differential targeting of Ca and Cb to different subcellular compartments.
To understand better why Cb fails to substitute for Ca in Ca 2/2 embryos, we analyzed whether the absence of Ca affects phosphoproteins involved in early developmental cell fate decisions: PP2A subunits associate with components of the wnt signaling pathway (Hsu et al., 1999; Seeling et al., 1999) , and may be involved in the regulation of wnt signaling by inhibiting GSK3b kinase. Wnt/Wingless proteins are a large family of cysteine-rich secreted molecules associated with the extracellular matrix. They control patterning and cell fate decisions in embryonic development via the activation of such cell-surface receptors as frizzled (Eastman and Grosschedl, 1999; Gradl et al., 1999) . A large body of genetic and biochemical evidence indicates that b -catenin is a key component of the Wnt signaling pathway: In the absence of Wnt signals, b -catenin is present in two distinct complexes. One complex is located at the plasma membrane where it couples cadherins to the actin cytoskeleton. The other complex is located in the cytoplasm, it contains the adenomatous polyposis coli protein (APC), axin, and glycogen synthase kinase 3b (GSK3b ). GSK3b regulates wnt signal-ing by inactivating b -catenin through phosphorylation, a targeting signal for its degradation (Yost et al., 1996; Yamamoto et al., 1999) . Wnt signaling antagonizes the axin/APC/ GSK3b complex, and blocks GSK3b activity, resulting in an increased pool of free cytoplasmic unphosphorylated b-catenin that translocates to the nucleus where it activates transcription of such wnt target genes as T-brachyury.
In contrast to the previous consensus that PP2A is a cytoplasmic protein (Cohen, 1989; Mumby and Walter, 1993; Shenolikar, 1994) , accumulating evidence suggests that it is also present in additional structures including nuclei (Sontag et al., 1995; Turowski et al., 1995) , consistent with the presence of a potential nuclear localization signal within the PR72 regulatory subunit of PP2A (Hendrix et al., 1993) . Moreover, subcellular fractionation revealed signi®-cant amounts of PP2A within the endoplasmic reticulum and the Golgi apparatus (Sontag et al., 1995) . Patterns of subcellular localization may be determined by regulatory B subunits: The B56a , B56b , and B56e regulatory subunits of PP2A are localized in the cytoplasm, whereas B56d , B56g 1, and B56g 3 are concentrated in nuclei (McCright et al., 1996) .
Possible differences in the localization of PP2A Ca and Cb are unknown. Here, we report that Ca and Cb are differently localized. In early embryos Ca was predominantly present at the plasma membrane whereas Cb was mainly present in both the cytoplasm and in nuclei. Moreover, b -catenin was colocalized with Ca at the plasma membrane. PP2A formed a complex with E-cadherin and b -catenin as shown by coimmunoprecipitation experiments. Both E-cadherin and b -catenin were redistributed from the plasma membrane to the cytoplasm in the absence of Ca . Cytoplasmic localization of b -catenin was not accompanied by nuclear translocation, but by accelerated degradation, probably due to phosphorylation.
Our data demonstrate that PP2A plays a critical role in the localization and distribution of E-cadherin and b -catenin, and they suggest that plasma membrane-associated Ca , but not Cb , is required to stabilize the E-cadherin/b-catenin complex in the plasma membrane. Thus, Ca and Cb have different functions in early development, possibly by determining substrate speci®city of PP2A.
Results
2.1. Plasma-membrane association of the catalytic subunit Ca of PP2A in the inner cell mass of early embryos PP2A is one of the predominant protein serine/threonine phosphatases in most cells and tissues, but relatively little is known about its subcellular distribution. Numerous biochemical studies have suggested that PP2A is largely a soluble cytosolic protein (Cohen, 1989; Mumby and Walter, 1993; Shenolikar, 1994) . Recent studies have shown that signi®cant amounts of PP2A are also present in the nucleus . Studies using subcellular fractionation and immuno¯uorescence have shown that signi®cant amounts of PP2A are localized in the endoplasmic reticulum, the Golgi, and the nucleus (Sontag et al., 1995) .
In order to determine whether PP2A Ca and PP2A Cb are differently localized in the developing embryo before PP2A Ca knockout embryos start to degenerate (which happens around embryonic day (E) 6.5), blastocyst cultures (E3.5) derived from wild-type mice were analyzed by confocal microscopy employing different anti PP2A catalytic subunit antisera (Go Ètz et al., 1998) .
Fixed blastocysts stained for PP2A Ca (Fig. 1A) and bcatenin (Fig. 1B) demonstrated that a signi®cant proportion of Ca was plasma membrane-associated, and that it colocalized with membrane-associated b -catenin (Fig. 1C) . Colocalization was most pronounced in the inner cell mass. At the rim of the colony, where the pluripotent inner cell mass cells started to differentiate into primitive endoderm (Kemler et al., 1981) , larger amounts of Ca were present in the cytoplasm (Fig. 1A) , suggesting that membrane association may be lost during differentiation. In contrast, the non-selective Ca /b antiserum V598A, revealed a localized, yet less membrane-speci®c localization of Ca /b (Fig. 1D) . Immunostaining of b -catenin (Fig.  1E ) showed in the overlay that Ca /b was additionally localized in some nuclei (Fig. 1F) con®rming that PP2A is not a strictly cytoplasmic protein as previously thought, but also present in nuclei in a cell-cycle dependent manner . Selective staining of Cb (Fig. 1G ) along with b -catenin (Fig. 1H ) revealed in the overlay (Fig.  1I ) that Cb was not strictly colocalized with b -catenin, and that it was not restricted to the plasma membrane.
The different localization of Ca and Cb is illustrated by a computed¯uorescence intensity pro®le along a straight line through the embryos (Fig. 2) . In the inner cell mass, the maxima of the intensities of Ca -and b -catenin-speci®c uorescence overlapped perfectly ( Fig. 2A) . Within the primitive endoderm, signi®cant amounts of Ca were localized in the cytoplasm ( Fig. 2A) . No overlapping peaks representing Cb and b-catenin were found (Fig. 2B) , con®rming that Cb is mainly localized in the cytoplasm or proximal to the plasma membrane.
Role of PP2A Ca in plasma-membrane localization of E-cadherin
It has recently been shown, that E-cadherin 2/2 embryonic stem cells are defective in cell aggregation; this defect can be corrected by transfection with cDNA for either Ecadherin or N-cadherin driven by a constitutive promoter. The presence (or absence) of E-cadherin regulates the expression of the transcription factor T-brachyury, indicating that cadherins play a role in linking cell surface receptors and gene expression.
While differentiating E-cadherin 2/2 ES cells are still able to express various early and late differentiation markers, they show a de®ciency in forming organized structures (Larue et al., 1996) , similar to PP2A Ca 2/2 embryos (Go Ètz et al., 1998) .
In order to determine whether localization of E-cadherin is affected by PP2A Ca , E6.5 embryos were ®xed within their decidua, and stained with an anti-E-cadherin antiserum. In wild-type embryos, we observed massive expression and membrane-association of E-cadherin in the embryo proper, but not in the surrounding decidua (Fig. 3A) . In contrast, E-cadherin was low in Ca 2/2 embryos and staining was dispersed with almost no membrane-association. Cells were not so tightly opposed to one another in Ca 2/2 embryos in comparison to controls (Fig. 3B) . To test the possibility that reduced levels of E-cadherin was related to cell death rather than to the lack of Ca, we analyzed its expression in E3.5 blastocyst cultures, 3 days before the embryos started to die. All wild-type blastocysts revealed membrane association of E-cadherin (Fig. 4A) . By combining the bright-®eld image with the confocal image, the size and shape of the cultured blastocyst became visible (Fig.  4C ). In contrast, one quarter of all cultured blastocysts obtained from heterozygous matings (i.e. Ca 2/2 blastocysts) showed a very disperse distribution of E-cadherin ( Fig. 4D) . At a lower magni®cation (Fig. 4D) , the cell boarders were generally still visible, at a fourfold higher magni®cation, however (Fig. 4E ), the dispersed distribution of Ecadherin was obvious, when compared to the wild-type situation (Fig. 4B ). Combining bright-®eld and confocal images ( Fig. 4F) , revealed an altered distribution of Ecadherin, but no reductions as in E6.5 embryos were found. Fig. 1 . Confocal analysis reveals that in the inner cell mass, PP2A Ca is mainly plasma membrane-associated. Fixed blastocysts stained for PP2A Ca (A) and b-catenin (B) demonstrated that a signi®cant proportion of Ca was plasma membrane-associated, and that it colocalized with membrane-associated b -catenin (C). Colocalization was most pronounced in the inner cell mass. At the rim of the colony, where pluripotent inner cell mass cells started to differentiate into primitive endoderm, larger amounts of Ca were present in the cytoplasm (A), suggesting that membrane association may be lost during differentiation. In contrast, the non-selective Ca/b antiserum V598A revealed a localized, yet less membrane-speci®c localization of Ca/b (D). Immunostaining of b-catenin (E) revealed in the overlay that Ca/b was additionally localized in nuclei (F). Selective staining of Cb (G) along with b-catenin (H) revealed in the overlay (I) that Cb was not strictly colocalized with b -catenin, and that it was not restricted to the plasma membrane.
Low levels of b -catenin in Ca
2/2 blastocysts Wnt/Wingless proteins, a large family of cysteine-rich secreted molecules associated with the extracellular matrix, control embryonic patterning and cell-fate decisions in embryonic development. A large body of genetic and biochemical evidence has identi®ed b -catenin as a key component of the Wnt signaling pathway. In the absence of Wnt signals, b-catenin is found in two distinct complexes. One complex, located at the plasma membrane, couples cadherins with the actin cytoskeleton whereas the other complex ± containing the proteins adenomatous polyposis coli (APC), axin, and glycogen synthase kinase 3b (GSK3b ) ± targets bcatenin for degradation (Fig. 6 ). Wnt signaling antagonizes the APC/axin/GSK3b complex, resulting in an increase in the pool of free cytoplasmic b -catenin.
Because the absence of Ca caused a marked down-regulation and profoundly different distribution of E-cadherin, we analyzed the subcellular localization of the E-cadherin-interacting protein b-catenin in cultured blastocysts. In the wildtype condition, Ca ( Fig. 1A ) and b -catenin ( Fig. 1B) were colocalized at the plasma membrane (Fig. 1C ). In contrast, cellular levels of b -catenin were signi®cantly lower in Ca 2/ 2 blastocysts (Fig. 5A ), and staining was more dispersed and less con®ned to the membrane. For negative controls, primary antibodies were omitted (Fig. 5B) .
Complex formation of PP2A, b -catenin, and Ecadherin
In the cytoplasm, b -catenin is present in a wnt signaling complex that includes axin, APC, and GSK-3b kinase. Recently, PP2A has been shown to bind to some components of this complex (Hsu et al., 1999; Seeling et al., 1999) . At the plasma membrane, b -catenin couples E-cadherin to the cytoskeleton. Our confocal microscopy analysis of Ecadherin and b -catenin in wild-type and Ca 2/2 blastocyst cultures suggested that PP2A may be found in the membrane-associated complex as well. In order to have suf®cient material for biochemical studies, undifferentiated wild-type embryonic stem cells (an equivalent of the inner cell mass) were lysed and immunoprecipitated with either a combination of anti-PP2A antisera, an E-cadherin-speci®c antibody, or a b -catenin-speci®c antibody, respectively. The immunoprecipitated proteins were separated by sodium dodecyl sulfate±polyacrylamide gel electrophoresis (SDS± PAGE), transferred to a nylon membrane and incubated with an E-cadherin-speci®c antibody. E-Cadherin coimmunoprecipitated with PP2A, and complex formation occurred in the presence or absence of EDTA (Fig. 6A ). Stripping and reprobing with a b -catenin-speci®c antibody revealed that b-catenin is also included in this complex (Fig. 6B) . As negative controls, lysates were incubated with protein A/ G-agarose without antibodies (Fig. 6, lanes 3 and 9) . As positive control for Western blot detection, an aliquot of the initial lysate was loaded (Fig. 6, lanes 6 and 12) .
Discussion
Homozygous Ca 2/2 embryos start to degenerate at embryonic day 6.0±6.5. Normally, at this time gastrulation is initiated. We have shown by immunohistochemistry and in whole-mount preparations that Ca is absent from Ca 2/2 embryos and that Cb is most likely upregulated (Go Ètz et al., 1998) . In blastocyst cultures neither maternal nor zygotic Ca is detectable in Ca 2/2 blastocyst cultures (Fig. 5A ). This is consistent with the observation that in Xenopus high levels of both Ca and Cb decrease rapidly during the meiotic and ®rst mitotic cell divisions (Van Hoof et al., 1995) . This rapid decline in message levels may be related to the presence within the 3 H UTR of ®ve copies of the AUUUA motif known to mediate rapid mRNA turnover . We have shown that no mesoderm is induced in In the inner cell mass, the maxima of the intensities of Ca -and b-cateninspeci®c¯uorescence overlapped perfectly (A). Within the primitive endoderm, signi®cant amounts of Ca were localized in the cytoplasm (A). No overlapping peaks representing Cb and b-catenin were found (B), con®rm-ing that Cb is mainly localized in the cytoplasm or proximal to the plasma membrane.
Ca
2/2 embryos, and that mesoderm-speci®c transcripts including goosecoid and T-brachyury are absent in Ca 2/2 embryos (Go Ètz et al., 1998) . The results of the present study suggest that this phenotype may be related to distinct subcellular localization of PP2A Ca and Cb . Ca was localized within the plasma membrane in the pluripotent inner cell mass of the early embryo. It was colocalized within this compartment with b -catenin. In the primitive endoderm, Ca showed a more cytoplasmic distribution, suggesting that membrane association of Ca is lost during differentiation. In contrast, Cb was mainly localized within both nuclei and the cytoplasm. Nuclear localization of PP2A has been clearly shown in previous studies (Sontag et al., 1995; . Our novel observation is that PP2A Ca was predominantly localized to the plasma membrane of the inner cell mass. This difference in cellular localization between Ca and Cb could be due to an unknown targeting signal in Ca for plasma membrane localization of the PP2A holoenzyme complex, or due to a regulatory B subunit that selectively associates with Ca , and targets the entire holoenzyme complex to the plasma membrane.
The phosphoprotein staphmin is a substrate of both Ca and Cb showing that at embryonic day 6.5, staphmin is localized in a subcellular compartment shared between the two PP2A catalytic subunits (data not shown).
In contrast, subcellular localizations of the PP2A substrates E-cadherin and its binding partner, b -catenin, were altered in Ca 2/2 embryos. Cellular levels of E-cadherin were signi®cantly reduced in E6.5 Ca 2/2 embryos, and remaining E-cadherins were dispersed throughout the cytoplasm with almost no membrane association. Reduced E-cadherin levels may be related to cell death rather than to the lack of Ca , however, because no reductions, but dispersed cytoplasmic distribution, was found in E3.5 blastocyst cultures. Analysis of the subcellular localization of the E-cadherin-interacting protein b -catenin in cultured blastocysts showed that in the absence of Ca, b -catenin was translocated to the cytoplasm and that its cellular levels were signi®cantly lower as compared to the wild-type condition. b -Catenin localization in the PP2A Ca 2/2 mutant (Fig. 5A ) needs to be compared with the wild-type control in Fig. 1B to avoid redundancy in the ®gures. The`no antibody' control is without the primary, but with both secondary antibodies to control for their speci®city. There was a slight background with the FITC-conjugated secondary antibody that was frequently observed (Fig.  5B) . This non-speci®c background supports our interpretation that PP2A Ca is plasma-membrane localized in Fig. 1A .
E-Cadherin, a transmembrane glycoprotein involved in Ca 21 -dependent cell±cell adhesion, and b-catenin have central functions in embryonic development, tissue formation, and in cell fate decision . ECadherin is expressed during early embryonic development in all cell types (Fig. 7A ) until its transcription is downregulated by wnt signals in mesoderm cells at the gastrulation stage (Fig. 7B) (Vestweber and Kemler, 1984; Butz and Larue, 1995) , when mesoderm-speci®c genes including Tbrachyury (Herrmann, 1991) are expressed. Anti-Ecadherin antibodies block compaction and blastocyst form- Fig. 3 . In the absence of Ca, E-cadherin expression is affected at a time when the embryo begins to degenerate. In order to determine whether E-cadherin expression is affected by PP2A Ca , Ca 2/2 and wild-type E6.5 embryos were ®xed within their decidua, and stained with an anti-E-cadherin antiserum. In wildtype embryos, we observed massive expression and membrane-association of E-cadherin in the embryo, but not in the surrounding decidua (A). In contrast, Ecadherin was low in Ca 2/2 embryos and staining was dispersed with almost no membrane-association (B).
ation during mouse preimplantation development (Vestweber and Kemler, 1985) . E-Cadherin null mutant mouse embryos are de®cient in forming a trophectoderm epithelium (Larue et al., 1994) . Several lines of evidence suggest that cadherins are involved in signaling from the cell surface to the nucleus. Embryonic stem cells lacking E-cadherin (Ecad
) express T-brachyury in contrast to wild-type stem cells, indicating that the presence of E-cadherin suppresses T-brachyury expression (Larue et al., 1996) . Subcutaneous injection of E-cad 2/2 embryonic stem cells into syngeneic hosts demonstrated the absence of organized structures in Ecad 2/2 teratomas (Larue et al., 1996) . We observed a similar phenotype in Ca 2/2 embryos which lacked structural organization (Go Ètz et al., 1998) .
b-Catenin is present in two compartments: a membraneassociated form couples E-cadherin to the cytoskeleton, and a cytoplasmic form is associated with a wnt signaling complex that includes the serine/threonine kinase GSK3b , axin, APC, and b -catenin (Fig. 6A) . Wnt signaling is initiated by binding of Wnt/Wingless ligands to the frizzled family of transmembrane receptors (Fig. 7B) . In the absence of Wnt signals, b-catenin is phosphorylated by GSK3b (Yost et al., 1996; Yamamoto et al., 1999) and thus targeted for degradation. Wnt signaling antagonizes the APC/axin/ GSK3b complex, and increases the pool of free cytoplasmic b-catenin that translocates into the nucleus and activates the transcription of wnt target genes. In b -catenin null-mutant embryos, development of the embryonic ectoderm is affected and no mesoderm is forming (Haegel et al., 1995) .
Our data suggest that PP2A is involved in wnt signaling. One likely explanation is that PP2A containing the Ca subunit binds to and stabilizes the E-cadherin/b -catenin complex within the plasma membrane. We found that PP2A forms a complex with b -catenin and E-cadherin. It is likely that PP2A regulates the phosphorylation status of E-cadherin and b -catenin at the plasma membrane. In the cytosol, the activity of PP2A may not be high enough to offset GSK3b -mediated phosphorylation of b -catenin (Fig.  7A) . Wnt signaling increases cytoplasmic concentrations of PP2A by releasing it from the plasma membrane into the cytosol. Increased concentrations of PP2A effectively offset the GSK3b-mediated phosphorylation of b -catenin thus preventing its degradation, and promoting its translocation to the nucleus with subsequent activation of wnt target Fig. 4 . Confocal microscopy of E-cadherin in cultured blastocysts. Blastocyst (embryonic day 3.5) cultures derived from heterozygous and wild-type matings were analyzed for E-cadherin expression. All wild-type blastocysts revealed membrane association of E-cadherin (A). By combining the bright-®eld image with the confocal image, the size and shape of the cultured blastocyst became visible (C). In contrast, one quarter of all cultured blastocysts obtained from heterozygous matings showed a very disperse distribution of E-cadherin (D). At a lower magni®cation (D), the cell borders were generally still visible, at a fourfold higher magni®cation; however (E), the dispersed distribution of E-cadherin was obvious, when compared to the wild-type situation (B). Combining bright-®eld and confocal images (F) revealed an altered distribution of E-cadherin, but no reductions as for E6.5 embryos were found. genes (Fig. 7B) . We found that in the Ca knockout situation both E-cadherin and b -catenin were no longer stabilized in the plasma membrane. It is likely that both are phosphorylated and translocated to the cytoplasm. Our data show that cytoplasmic E-cadherin is stable, and suggest that the associated b-catenin is targeted for degradation resulting in reduced b -catenin levels (Fig. 7C) . We propose that in the absence of PP2A Ca , wnt signaling releases b -catenin from the axin/APC/GSK3b complex, b -catenin associates with the highly abundant cytoplasmic E-cadherin before it reaches the nucleus; it is phosphorylated and becomes degraded. Consequently, no target genes of wnt signaling including Brachyury or goosecoid are transcribed (Fig. 7D) and embryonic development halts (Go Ètz et al., 1998) . This model is consistent with our ®nding that Ca is mainly plasma membrane-associated in the inner cell mass, but that this association becomes lost during differentiation.
This model would also explain why the wnt target gene Tbrachyury is negatively regulated by E-cadherin: T-brachyury mRNA levels are high in E-cad 2/2 embryonic stem cells (ES) cells, but absent in wild-type ES cells (Larue et al., 1996) . Basal cytoplasmic levels of non-phosphorylated bcatenin may be quenched by cytoplasmic or membranebound E-cadherin (Fig. 7D ), preventing transcription of Tbrachyury in the absence of a wnt signal. In E-cad 2/2 cells, the quencher is missing allowing low but signi®cant amounts of non-phosphorylated b -catenin to be translocated into the nucleus, and to activate transcription of T-brachyury. This is consistent with the structural organization of b-catenin itself; most of its protein-interacting motifs overlap so that interaction with one partner can block binding of another at the same time. Using recombinant proteins, it was found that E-cadherin and lymphocyte-enhancer factor-1 (LEF-1) which targets b-catenin to the nucleus, form mutually exclusive complexes with b-catenin (Orsulic et al., 1999) .
This model is also consistent with the known association of PP2A with axin (Hsu et al., 1999) . Axin is a negative regulator of embryonic axis formation in vertebrates (Seeling et al., 1999) . It acts through wnt signaling and involves both GSK3b and b-catenin. Two spontaneous alleles, axin Ki and axin Kb cause recessive lethality at embryonic days 8±10. Embryos homozygous for any of the recessive lethal alleles show frequent neuroectodermal defects, including truncation or incomplete closure of the anterior neural folds, and cardiac defects (Hsu et al., 1999) . We have recently shown that PP2A Ca is highly enriched in neural folds (Go Ètz and Kues, 1999) . The interaction of Ca with axin interaction may thus be involved in the neuroectodermal phenotype of axin Ki and axin Kb mutants. The transformation of epithelial cells to mesenchymal cells is of critical importance not only during embryonic development. In adult tissue such changes are important for oncogenic and invasive properties of tumor cells derived from epithelial origins. Carcinomas frequently loose expression of E-cadherins, and thus become more invasive. When the integrin-linked kinase ILK is modestly overexpressed in epithelial cells (Novak et al., 1998) , as in PP2A Ca 2/2 embryos, E-cadherins are down-regulated, followed by Fig. 5 . Confocal microscopy of b -catenin in cultured blastocysts. Because the absence of Ca caused a marked down-regulation and profoundly different distribution of E-cadherin, we analyzed the subcellular localization of the E-cadherin-interacting protein b-catenin in cultured blastocysts depending on the expression of Ca. Ca 2/2 blastocysts expressed b-catenin at signi®cantly lower levels (A) compared to wild-type blastocysts, and staining was more dispersed and less con®ned to the membrane. The PP2A Ca 2/2 mutant (A) needs to be compared with the wild-type control in Fig. 1B to avoid redundancy in ®gures. The`no antibody' control is without the primary, but with both secondary antibodies to control for their speci®city. There was a slight background with the FITC-conjugated secondary antibody that was frequently observed (B). This non-speci®c background supports our interpretation that PP2A Ca is plasma-membrane localized in Fig. 1A. translocation of b -catenin to the nucleus. In nude mice, overexpression of constitutively active ILK results in tumorigenicity (Wu et al., 1998) . The molecular basis for increased invasiveness is incompletely understood, but may involve the activation of mesenchymal genes, and transformation to a more mesenchymal phenotype. Interestingly, the PR65a subunit of PP2A is a putative human tumor suppressor gene (Wang et al., 1998) .
Further studies are required to determine whether Ecadherin, b -catenin, or p120 become hyperphosphorylated, whether LEF-1 mediates transcription or whether the af®-nity of b-catenin for E-cadherin is altered.
In conclusion, we de®ned a novel subcellular compartment for PP2A: the plasma membrane. The failure of the mainly cytoplasmically and nuclearly localized Cb subunit to compensate for the lack of the mainly plasma-membrane associated Ca subunit suggests that membrane localization of PP2A is important for stabilizing the E-cadherin/b-catenin complex at the plasma membrane. The results suggests that PP2A is involved in wnt signaling during early embryonic development.
Experimental procedures
4.1. PP2A Ca 2/2 mice For homologous recombination, more than 0.5 kb of the Ca promoter, exon 1, and 0.3 kb of intron 1 were replaced by a neomycin resistance cassette constitutively transcribed from a phosphoglycerate kinase promoter inserted in opposite transcriptional orientation. Two independent embryonic stem cell clones allowed germ line transmission of the mutated allele. Two mouse strains with identical phenotypes were established. PP2A Ca 2/2 embryos developed normally until post-implantation, around embryonic days 5.5±6.0. While no Ca protein was expressed, we found equal expression levels of PP2A C at a time when Ca 2/2 embryos are degenerating. Degenerated embryos can be recovered even at day E13.5, indicating that the embryonic tissue is still capable of proliferating without Ca , but that its normal differentiation is signi®cantly impaired: The primary germ layers ectoderm and endoderm were formed, but mesoderm formation was absent in degenerating Ca 2/2 embryos (Go Ètz et al., 1998) .
Blastocyst culture
To obtain homozygous PP2A1/ Ca 2/2 blastocysts, heterozygous Ca 1/2 female mice (Go Ètz et al., 1998) were hormonally stimulated with gonadotropins (Veterinaria), and crossed with heterozygous Ca 1/2 male mice. Matings with wild-type male mice were included as controls. Blastocysts were obtained 3.5 days post coitum by¯ushing the uterine horns, and were cultured on gelatine (Hogan et al., 1994) in DMEM (Gibco BRL) supplemented with 20% fetal calf serum (Eurobio). After 2±4 days, blastocysts lost the zona pellucida, adhered to the culture dishes, and the inner cell mass of the blastocysts became visible on top of a layer of trophectodermal cells. Genotyping of blastocysts and paraf®n sections was done as described (Haegel et al., 1995; Go Ètz et al., 1998) .
Antibodies
All primary antisera were af®nity puri®ed. The rabbit anti-PP2A C antiserum V598A (Promega) directed against Fig. 6 . PP2A, E-cadherin, and b -catenin exist in a complex. Undifferentiated wild-type embryonic stem cells (an equivalent of the inner cell mass of blastocysts) form complexes containing PP2A, E-cadherin, and b-catenin as revealed by coimmunoprecipitation experiments. Lysates were incubated with an antibody speci®c for b -catenin (lanes 1, 7), with a combination of PP2A-speci®c antibodies in the presence (lanes 2, 8) or absence (lanes 4, 10) of EDTA, with no antibody (lanes 3, 9), and with an antibody speci®c for E-cadherin (lanes 5, 11). In addition to the immunoprecipitates, a lysate control was loaded (lanes 6, 12). Samples were separated by SDS±PAGE, gels transferred to nylon membranes, and analyzed by Western blotting using an E-cadherin-speci®c antibody (A). The blots were stripped and reprobed with a b-catenin-speci®c antibody (B). The size of the protein weight marker is given in kDa. The position of the 120 kDa band representing E-cadherin and the 92 kDa band representing b-catenin is indicated by an arrow. Fig. 7 . Model describing interactions of PP2A Ca , b -catenin and E-cadherin (®gure partly adopted from Eastman and Grosschedl, 1999) In the absence of a wnt signal, b-catenin binds to cadherins and mediates interactions with the actin cytoskeleton. We propose that PP2A containing the Ca subunit stabilizes the E-cadherin/b-catenin complex at the plasma membrane (A). Cytoplasmic b-catenin interacts with the axin/APC/GSK3b complex. GSK3b phosphorylates bcatenin and APC, leading to the degradation of b-catenin. Transcription of wnt target genes is prevented. Levels of cytoplasmic PP2A may not be high enough to offset phosphorylation of b-catenin (A). It is likely that in the Ca knockout situation, E-cadherin and b-catenin become phosphorylated and are translocated to the cytoplasm. Cytoplasmic E-cadherin is stable, but the associated b-catenin is degraded (C). We propose that in the absence of PP2A Ca, wnt signaling releases b-catenin from the axin/APC/GSK3b complex, b -catenin associates with cytoplasmic E-cadherin before it reaches the nucleus, is phosphorylated and becomes degraded. No wnt target genes such as Brachyury or goosecoid are transcribed (Go Ètz et al., 1998) (D) . In the wild-type embryo expressing Ca, wnt signaling down-regulates E-cadherin. Binding of a Wnt ligand to the frizzled receptor activates disheveled (not shown), which inhibits the activity of the axin/ APC/GSK3b complex of proteins. Increased concentrations of PP2A effectively offset the GSK3b -mediated phosphorylation of b -catenin thus preventing its degradation, and promoting its translocation to the nucleus with subsequent activation of wnt target genes (B). a C-terminal sequence shared by Ca and Cb was used at 1:100 dilutions for immunohistochemistry. The selective rabbit anti-Ca antiserum #45 (generous gift from Dr. B. Hemmings) directed against the ®rst 20 residues of Ca that are highly diverse between Ca and Cb was used at a 1:100 dilution for immunohistochemistry (Go Ètz et al., 1998) . The rabbit anti-Cb antiserum #15 (generous gift from Dr. B. Hemmings) directed against residues 22±31 of Cb that are also highly diverse between Ca and Cb was used at 1:25 dilutions for immunohistochemistry (Go Ètz et al., 1998) . For confocal analyses, all anti-PP2A (C, Ca, and Cb ) antisera were used at 1:100 dilutions.
Rabbit antiserum anti-gp84 (Vestweber and Kemler, 1984) directed against E-cadherin (generous gift from Dr. R. Kemler) was used at 1:25 dilutions for immunohistochemistry, and a mouse monoclonal antibody speci®c for b -catenin (C19220, Transduction Laboratories) was used at 1:100 dilutions.
FITC anti-mouse Ig and FITC anti-rabbit Ig (Cappel), Cy5 anti-mouse Ig, Cy5 anti-rabbit Ig and Cy3 anti-mouse Ig (Jackson Immuno Research) were used as secondary antibodies at 1:100 dilutions. For immunodetection of Ecadherin and staphmin on sections, a biotinylated anti-rabbit secondary antiserum (Vector Laboratories) was used at 1:200 dilutions.
Immunohistochemistry
Embryos within their decidua were ®xed in 4% formaldehyde in PBS overnight at room temperature, dehydrated in graded alcohols, embedded in paraf®n, sectioned sagitally (2-to 3-mm sections), and stained with hematoxylin±eosin. Immunoreactions were detected with the Vectastain ABC kit (Vector Laboratories) by using 5% NiCl 2 and diaminobenzidine as a substrate. Speci®cities of staining were con®rmed by concurrent processing of tissue sections without the primary antisera.
Confocal microscopy
Blastocyst cultures were washed in PBS, ®xed in 4% formaldehyde in microtubule stabilization buffer (65 mM PIPES, 25 mM HEPES, 10 mM EGTA, 3 mM MgCl 2 , pH 6.9) for 3.5 h, washed with 0.1% Triton X-100 in PBS, and incubated three times for 10 min in freshly prepared sodium borohydrate (10 mg/ml). Fixed blastocysts were either dehydrated in 100% methanol for storage at 2208C, or directly processed. For the detection of PP2A C, Ca , Cb , and b -catenin, blastocyst cultures were ®xed in Dent's ®xa-tive (Methanol/DMSO 4:1) for 3 h at 48C (Dent et al., 1989) . After blocking with 5% sheep serum (Sigma), 1% BSA, and 1£ TBS for 3 h at room temperature, primary antisera were added in 1% BSA, 0.05% Tween-20, 1£ TBS overnight at 48C. Following washes in TBS, 0.5% Tween-20, the secondary FITC-or Cy5-labeled antisera were added for overnight incubations at 48C. Labeled blastocysts were washed and mounted in 0.1 M Tris±HCl (pH 9.5)/glycerol (3:7) including 50 mg/ml n-propyl gallate as anti-fading reagent (Messerli et al., 1993) . Blastocysts were viewed by using a Leica TCS confocal microscope, and images were processed with the IMARIS software package (Bitplane, Zu Èrich, Switzerland).
Coimmunoprecipitation and Western blot analysis
Wild-type embryonic stem cells were grown in the presence of LIF on mitomycin C-arrested murine embryonic ®broblasts to prevent differentiation (Hogan et al., 1994) . Cells were scraped in TN lysis buffer (50 mM Tris (pH 8.0), 150 mM NaCl, 0.1% NP-40, 1/2 1 mM EDTA) in the presence of protease inhibitors (5 mg/ml pepstatin A, 5 mg/ml leupeptin, 5 mg/ml aprotinin, 0.5 mg/ml Pefabloc, 100 mM ammonium molybdate) by vigorous agitation for 20 min at 48C. An aliquot of the lysate (1/400 of the total volume) was removed and directly used for SDS±PAGE. Equal amounts of lysates (derived from 1±4 £ 10 6 cells) were incubated o/n at 48C on a rotating wheel with ProtA/ProtG-agarose (Boehringer Mannheim) preabsorbed with either (a) no antibody, (b) antibody C19220 (Transduction Laboratories) speci®c for b -catenin, (c) antibody C20820 (Transduction Laboratories) speci®c for E-cadherin, or (d) a mixture of PP2A-speci®c antisera (antiserum V598A (Promega) directed against a C-terminal sequence shared by Ca and Cb , rabbit anti-Ca antiserum #45, rabbit anti-PP2A 65a-speci®c antiserum #35 (Evans et al., 1999) ). The immunoprecipitates were washed ®ve times and run on an 8% SDS±PAGE gel. Gels were transferred to Hybond-ECL membranes (Amersham), blocked in 10% milk, and incubated with the monoclonal antibodies C19220 (anti-b -catenin) or C20820 (anti-E-cadherin), respectively. Immunodetection was done by chemiluminescence (ECL, Amersham) according to the manufacturer's recommendations.
